Analysts think TELO stock price could increase by 278%
Mar 27, 2025, 11:25 AM
-37.86%
What does TELO do
Telomir Pharmaceuticals, a preclinical-stage company based in Tampa, Florida, focuses on developing TELOMIR-1 to lengthen DNA's telomere caps for age reversal. It went public on February 9, 2024.
3 analysts think TELO stock price will increase by 277.55%. The current median analyst target is $15.55 compared to a current stock price of $4.12. The lowest analysts target is $15.40 and the highest analyst target is $16.01.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
